Immuneering Corp. Files 8-K on Shareholder Vote Matters
Ticker: IMRX · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1790340
| Field | Detail |
|---|---|
| Company | Immuneering Corp (IMRX) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: IMRX
TL;DR
IMRX filed an 8-K for a shareholder vote on June 13th. Details to follow.
AI Summary
Immuneering Corp. filed an 8-K on June 16, 2025, reporting on a matter submitted to a vote of its security holders on June 13, 2025. The filing details the company's corporate information, including its address in Cambridge, MA, and its fiscal year end of December 31.
Why It Matters
This filing indicates a formal process involving shareholder decisions, which could impact corporate governance and future strategic directions for Immuneering Corp.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Immuneering Corp. (company) — Registrant
- June 13, 2025 (date) — Date of earliest event reported
- June 16, 2025 (date) — Date of report
- Cambridge, MA (location) — Principal executive offices
FAQ
What specific matter was submitted to a vote of Immuneering Corp.'s security holders?
The filing states that the report concerns 'Submission of Matters to a Vote of Security Holders' but does not specify the exact nature of the vote within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 13, 2025.
What is Immuneering Corp.'s principal executive office address?
Immuneering Corp.'s principal executive offices are located at 245 Main St., Second Floor, Cambridge, MA 02142.
What is Immuneering Corp.'s fiscal year end?
Immuneering Corp.'s fiscal year ends on December 31.
What is the SEC file number for Immuneering Corp.?
The SEC file number for Immuneering Corp. is 001-40675.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Immuneering Corp (IMRX).